Yes, in one larger human trial pasteurized Akkermansia increased GLP-1 in people with metabolic syndrome
Cela permet la formation dacyl-carnitine, qui traverse la membrane mitochondriale et est ensuite reconvertie en acyl-CoA, amorant ainsi la -oxydation
Other peptides like Semaglutide are FDA-approved but restricted to prescription use
101 YuanH.LiX.ZhangX.KangR.TangD
The NMA showed greater reductions in HbA 1c , BMI and SBP and greater improvements in blood lipid levels with once-weekly semaglutide than with PEG-loxenatide
So instead of letting the debate stall in binaries, we can push for: Broader access to both medications and nutrition counseling More investment in behavior support infrastructure, before, during, and after medication use Honest conversations about who profits from health messaging